Bristol-Myers Squibb to Pay $20M in Abilify Settlement
Abilify manufacturer, Bristol-Myers Squibb has reached a nearly $20 million Abilify settlement. This Abilify settlement is with 42 U.S. states and the District of Columbia after accusations the company improperly marketed the blockbuster antipsychotic drug Abilify (aripiprazole). The court found that Bristol-Myers Squibb unlawfully marketed Abilify to seniors with dementia and Alzheimer’s diseases. This is even though
Read More
Thirty Percent of Hernia Surgeries Could Have Used Faulty Hernia Mesh
Every year, 1 million people have their hernia repaired. They trust their doctors that this surgery is necessary for them to relieve their constant pain. Now, many are finding the hernia mesh used in their surgeries were rushed to market and is causing more damage than their hernia ever did. Thirty percent of hernia surgeries
Read More
Johnson & Johnson and Their Dangerous Legacy
For decades, Johnson & Johnson created a wholesome brand to appeal to the American consumer. They have tricked people into thinking their products are safe. However, more and more of their products are failing. Failing so gravely that serious harm is befalling those same innocent consumers who trusted their wholesome image. This is Michael Brady
Read More
Ethicon’s Physiomesh Flexible Composite Mesh Recall
Johnson & Johnson’s manufacturer, Ethicon issued a full recall of its Physiomesh Flexible Composite Mesh after two studies found higher rates of hernias re-opening versus similar products. What is Physiomesh Flexible Composite Mesh? Every year, surgeons perform around 150,000 ventral hernia repairs in the United States. Doctors can perform the operation laparoscopically or by opening
Read More